Letters
Microcephaly in Europe
Harness shared data in international Zika registry
BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i5319 (Published 05 October 2016) Cite this as: BMJ 2016;355:i5319- David Baud, maternal-fetal medicine specialist1,
- Patrick Gérardin, epidemiologist2,
- Audrey Merriam, maternal-fetal medicine fellow3,
- Marco P Alves, virologist4,
- Didier Musso, infectious disease specialist5,
- Blaise Genton, tropical medicine specialist6,
- Alice Panchaud, teratogen counsellor7
- 1Materno-Fetal and Obstetrics Research Unit, Department “Femme-Mère-Enfant,” University Hospital, 1011 Lausanne, Switzerland; Institute of Microbiology, Faculty of Biology and Medicine, University of Lausanne and University Hospital, Lausanne, Switzerland
- 2Pôle Femme Mère Enfant, Centre d’Investigation Clinique (INSERM CIC1410), UM 134 PIMIT “Processus Infectieux en Milieu Insulaire Tropical” (Université de La Réunion, CNRS 9192, INSERM U 1187, IRD 249), CHU Réunion, Saint Pierre, Réunion
- 3Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, New York, USA
- 4Institute of Virology and Immunology, Department of Infectious Diseases and Pathobiology, University of Bern, Switzerland
- 5Unit of Emerging Infectious Diseases, Institut Louis Malardé, Tahiti, French Polynesia
- 6Swiss Tropical and Public Health Institute, Basel, Switzerland; Infectious Disease Service and Department of Ambulatory Care, University Hospital Lausanne, Lausanne, Switzerland
- 7Swiss Teratogen Information Service, University Hospital, 1011 Lausanne, Switzerland; Division of Clinical Pharmacology, University Hospital, 1011 Lausanne, Switzerland; School of Pharmaceutical Sciences, University of Geneva and Lausanne, Geneva, Switzerland; Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
- david.baud{at}chuv.ch
We welcome the paper by Morris and colleagues on the prevalence of microcephaly in Europe.1 The authors state that increases in prevalence such as expected with Zika virus in a non-endemic region would be unlikely to be detected in Europe through routine surveillance.
As a newly identified teratogen, Zika requires global and dedicated tools to allow comprehensive characterisation of the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.